Incomes 78.14 60.33 Total Revenues 7,879.44 7,032.50 Selling & Administrative Expense 507.94 499.86 Finance Costs 90.76 94.42 Net Profit 443.44 121.25 Earnings per share (Baht) 1.11 0.30 The company would
Sir, Please find below the additional information in supportive of our financial statements ended June 30, 2018. Performance for the three-month period ended June 30, 2018 - Sales income increased 4.8
Dear Sir, Please find below the additional information in supportive of our financial statements for period ended September 30, 2018. Performance for the three-month period ended 30 September 2018
total assets (ROA) increased from 0.57% to 1.68% and the return on equity (ROE) increased from 0.72% to 2.27% and earnings per share (EPS) increased from 0.35 Baht/share to 1.06 Baht/share. The efficiency
1,820.49 Distribution Expense 63.21 50.30 Administrative Expense 59.70 73.65 Finance Costs 21.95 24.29 Net Profit 271.25 32.34 Earnings per share (Baht) 0.679 0.081 The comparison between Second Quarter of
director and chief advisor to the executive board before it was disclosed to the public. The Q3/2015 operating results showed the net earnings of 14.25 million baht, which was a significant increase compared
forward contracts and insurance claim income. ChangeConsolidated financial statements Q1-2020Q1-2021 *Extraordinary items from non-operating, consists of unrealized gain (loss) on exchange rate of
* Note Please find further information in the consolidated financial statements. 1 21 February, 2019 Subject: Management Discussion & Analysis (MD&A) for the year 2018 Attention: The President The
Exchange of Thailand The Board of Directors Meeting of Wattanapat Hospital Trang Public Company Limited (the “Company”) No. 3/2017, held on February 26, 2017, approving the audited consolidated financial
(THIS REPORT DISCUSSES PRINCIPAL CHANGES ON THE REVIEWED AND AUDITED CONSOLIDATED FINANCIAL STATEMENT) LH FINANCIAL GROUP PUBLIC COMPANY LIMITED MANAGEMENT DISCUSSION AND ANALYSIS FOR THE SECOND